Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Topical sodium nitrite is an investigational 2% cream formulation developed by Dr. Caterina P. Minniti and colleagues at the National Heart, Lung, and Blood Institute (NHLBI) for the treatment of chronic leg ulcers, particularly in patients with sickle cell disease. As a nitric oxide donor, sodium nitrite promotes vasodilation, thereby increasing peri-wound blood flow and oxygenation to the ulcer bed. Additionally, it exhibits bacteriostatic properties that may help reduce the bacterial load in chronic wounds. Clinical studies, including a Phase 2 trial funded by the FDA Office of Orphan Products Development, have evaluated its safety and efficacy in accelerating ulcer healing and reducing associated pain, with promising results observed in ulcers of shorter duration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on topical sodium nitrite.